 |
 |
ProductsCeladrin®- Imagenetix’s Lead Natural Based Product According to the Bone and Joint Decade, an independent global nonprofit organization, musculo-skeletal health challenges result in an estimated cost of $215 billion per year in the United States alone. Imagenetix’s lead product, which addresses a segment of this market, is Celadrin®. Celadrin® is a natural-based, scientifically tested, University researched product developed to provide support for healthy joint function and mobility. With an increasing base of consumers being introduced to the product, with world class athletes beginning to endorse the product, and with proper scientific, media, and distributor attention placed on the product, Imagenetix’s proprietary product, Celadrin®, is beginning to gain visibility. It could compete for market share very favorably against products such as glucosamine, a natural product that has annual sales of approximately $2 billion per year. Additional Proprietary Products One of the key segments of the Company's strategic plan is the ongoing development of new, innovative products. The Company has several proprietary products and formulations in various stages of development and clinical testing. Celadrin® Cream – Imagenetix has developed a topical cream designed for relief of joint pain. The Company has completed a double-blind, placebo-controlled, clinical studies to determine the scientific efficacy of Celadrin® cream. Three Celadrin cream studies have been published in peer reviewed medical journals. The Company believes the market for an effective cream could be larger then the market for its oral product which is targeted to provide support for healthy joint function and mobility. Anti-Wrinkle Cream – Imagenetix has developed and clinically studied a revolutionary age-defying skin cream. This cream is designed to diminish the appearance of wrinkles. The Company successfully completed a placebo-controlled clinical study. The Company plans on selling its own brand of age defying cream through its own infomercial, featuring Daniela Pestova. Psoriasis Cream - The Company has successfully completed a clinical trial to determine the scientific efficacy of a skin cream designed to provide relief to those who suffer from psoriasis. Whole Food Fruit and Vegetable Concentrates – These whole food concentrates containing a full array of whole food actives are in capsule form designed to increase oxidative stress protection and provide an array of health benefits. Genepril – The Company’s patent pending pharmaceutical product for the treatment of periodontal disease is in the early stages of drug development. Property Protection Imagenetix seeks to protect all of its properties through the various forms of protection that might be available to each individual product. Forms of protection the Company seeks for its products include tying up raw materials, contracting for exclusive development or marketing rights, trademarking names, entering into exclusive private label arrangements with distributors, filing patents, and completing clinical studies which link the Company’s specific and proprietary product to clinical evidence. |